-
公开(公告)号:US08133998B2
公开(公告)日:2012-03-13
申请号:US12118492
申请日:2008-05-09
申请人: Hassan Pajouhesh , Hossein Pajouhesh , Yanbing Ding , Jason Tan , Mike Grimwood , Francesco Belardetti , Ramesh Kaul , Richard Holland , Navjot Chahal
发明人: Hassan Pajouhesh , Hossein Pajouhesh , Yanbing Ding , Jason Tan , Mike Grimwood , Francesco Belardetti , Ramesh Kaul , Richard Holland , Navjot Chahal
IPC分类号: C07D491/00 , C07D333/00 , C07D333/52 , C07D333/38
CPC分类号: A61K31/496 , A61K31/5377
摘要: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity are disclosed. Specifically, a series of compounds containing thienopyrimidine or oxoquinazoline derivatives are disclosed of the general formula (1) or formula (2) where X is a linker and Y is an aromatic moiety or N(R5)(R6).
摘要翻译: 公开了有助于改善由不希望的钙通道活性,特别是不希望的T型钙通道活性表征的病症的方法和化合物。 具体地说,通式(1)或式(2)公开了一系列含有噻吩并嘧啶或氧代喹唑啉衍生物的化合物,其中X为连接基,Y为芳族部分或N(R5)(R6)。
-
公开(公告)号:US07511077B2
公开(公告)日:2009-03-31
申请号:US11351224
申请日:2006-02-08
申请人: Hassan Pajouhesh , Hossein Pajouhesh , Yanbing Ding , Terrance P. Snutch , Francesco Belardetti
发明人: Hassan Pajouhesh , Hossein Pajouhesh , Yanbing Ding , Terrance P. Snutch , Francesco Belardetti
IPC分类号: C07C211/09 , C07C233/30 , A61K31/165
CPC分类号: C07D401/12 , C07C233/78 , C07C235/20 , C07C235/50 , C07D213/38 , C07D213/40
摘要: Aromatic derivatives of aliphatic diamines are effective in ameliorating conditions characterized by unwanted calcium ion channel activity, especially T-type and N-type channels. These conditions include, for example, stroke and pain.
摘要翻译: 脂肪族二胺的芳族衍生物可有效改善特征在于不需要的钙离子通道活性的条件,特别是T型和N型通道。 这些病症包括例如中风和疼痛。
-
公开(公告)号:US20060235050A1
公开(公告)日:2006-10-19
申请号:US11351224
申请日:2006-02-08
IPC分类号: A61K31/444 , A61K31/44 , A61K31/165 , C07D213/56
CPC分类号: C07D401/12 , C07C233/78 , C07C235/20 , C07C235/50 , C07D213/38 , C07D213/40
摘要: Aromatic derivatives of aliphatic diamines are effective in ameliorating conditions characterized by unwanted calcium ion channel activity, especially T-type and N-type channels. These conditions include, for example, stroke and pain.
-
公开(公告)号:US07186726B2
公开(公告)日:2007-03-06
申请号:US10655393
申请日:2003-09-03
申请人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
发明人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
IPC分类号: A61K31/4965 , C07D295/00
CPC分类号: C07D295/185 , A61K31/4468 , A61K31/451 , A61K31/4515 , A61K31/454 , A61K31/4545 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5415 , C07D211/14 , C07D211/16 , C07D211/46 , C07D211/58 , C07D213/38 , C07D277/74 , C07D277/82 , C07D295/03 , C07D317/60 , C07D401/04 , C07D401/14
摘要: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
摘要翻译: 描述了可用于改变钙通道活性的某些哌嗪取代的化合物。
-
公开(公告)号:US20060084660A1
公开(公告)日:2006-04-20
申请号:US11214218
申请日:2005-08-29
IPC分类号: A61K31/495
CPC分类号: A61K31/495
摘要: Certain piperazine compounds are described which are useful in altering calcium channel activity.
摘要翻译: 描述了可用于改变钙通道活性的某些哌嗪化合物。
-
公开(公告)号:US06951862B2
公开(公告)日:2005-10-04
申请号:US10409763
申请日:2003-04-08
申请人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
发明人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
IPC分类号: A61K31/4468 , A61K31/451 , A61K31/4515 , A61K31/454 , A61K31/4545 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5415 , A61P9/10 , A61P25/08 , A61P25/22 , A61P25/24 , A61P29/00 , C07D211/14 , C07D211/16 , C07D211/46 , C07D211/58 , C07D213/38 , C07D277/74 , C07D277/82 , C07D295/02 , C07D295/03 , C07D295/185 , C07D317/60 , C07D401/04 , C07D401/14 , A61K31/4965 , C07D241/04
CPC分类号: A61K31/4468 , A61K31/451 , A61K31/4515 , A61K31/454 , A61K31/4545 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5415 , C07D211/14 , C07D211/16 , C07D211/46 , C07D211/58 , C07D213/38 , C07D277/74 , C07D277/82 , C07D295/03 , C07D295/185 , C07D317/60 , C07D401/04 , C07D401/14
摘要: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
-
公开(公告)号:US06949554B2
公开(公告)日:2005-09-27
申请号:US10746932
申请日:2003-12-23
申请人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
发明人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
IPC分类号: A61K31/4468 , A61K31/451 , A61K31/4515 , A61K31/454 , A61K31/4545 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5415 , A61P9/10 , A61P25/08 , A61P25/22 , A61P25/24 , A61P29/00 , C07D211/14 , C07D211/16 , C07D211/46 , C07D211/58 , C07D213/38 , C07D277/74 , C07D277/82 , C07D295/02 , C07D295/03 , C07D295/185 , C07D317/60 , C07D401/04 , C07D401/14 , A61K31/497 , A61K31/4965
CPC分类号: A61K31/4468 , A61K31/451 , A61K31/4515 , A61K31/454 , A61K31/4545 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5415 , C07D211/14 , C07D211/16 , C07D211/46 , C07D211/58 , C07D213/38 , C07D277/74 , C07D277/82 , C07D295/03 , C07D295/185 , C07D317/60 , C07D401/04 , C07D401/14
摘要: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
摘要翻译: 描述了可用于改变钙通道活性的某些哌嗪取代的化合物。
-
8.Calcium channel inhibitors comprising benzhydril spaced from piperazine 失效
标题翻译: 包含与哌嗪间隔的二苯甲基胺的钙通道抑制剂公开(公告)号:US06943168B2
公开(公告)日:2005-09-13
申请号:US10409868
申请日:2003-04-08
申请人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
发明人: Terrance P. Snutch , Gerald W. Zamponi , Hassan Pajouhesh , Hossein Pajouhesh , Francesco Belardetti
IPC分类号: A61K31/4468 , A61K31/451 , A61K31/4515 , A61K31/454 , A61K31/4545 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5415 , C07D211/14 , C07D211/16 , C07D211/46 , C07D211/58 , C07D213/38 , C07D277/74 , C07D277/82 , C07D295/02 , C07D295/03 , C07D295/185 , C07D317/60 , C07D401/04 , C07D401/14 , A61K31/497 , A61K31/4965 , C07D295/00 , C07D401/00
CPC分类号: C07D295/185 , A61K31/4468 , A61K31/451 , A61K31/4515 , A61K31/454 , A61K31/4545 , A61K31/495 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/5375 , A61K31/538 , A61K31/5415 , C07D211/14 , C07D211/16 , C07D211/46 , C07D211/58 , C07D213/38 , C07D277/74 , C07D277/82 , C07D295/03 , C07D317/60 , C07D401/04 , C07D401/14
摘要: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
摘要翻译: 描述了可用于改变钙通道活性的某些哌嗪取代的化合物。
-
公开(公告)号:US20080227823A1
公开(公告)日:2008-09-18
申请号:US12042277
申请日:2008-03-04
IPC分类号: A61K31/4439 , C07D401/12 , C07D209/04 , A61K31/404 , C07D211/06 , A61K31/4468
CPC分类号: A61K31/4045 , A61K31/4468 , A61K31/454 , C07C233/51 , C07C237/24 , C07C2601/14 , C07D209/14 , C07D211/66 , C07D213/56 , C07D401/04 , C07D401/12 , C07D405/14
摘要: Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity are disclosed. Specifically, a series of compounds containing both a diamide and aromatic functionality are disclosed of the general formula (1) where X1 and X2 are linkers.
摘要翻译: 公开了有效改善特征在于不希望的钙通道活性,特别是不希望的T型钙通道活性的病症的方法和化合物。 具体地,公开了一系列含有二酰胺和芳族官能团的化合物,通式(1)其中X 1和X 2 2是连接体。
-
公开(公告)号:US07270949B2
公开(公告)日:2007-09-18
申请号:US10754085
申请日:2004-01-07
IPC分类号: C12Q1/00
CPC分类号: G01N33/6872 , G01N33/582 , G01N33/6896 , G01N2500/00
摘要: A fluorescence based assay for compounds that modulate T-type calcium ion channels and that can be adapted to high throughput screening formats. Modulators of T-type channels are useful to correct functional abnormalities. These abnormalities are associated with epilepsy, pain, schizophrenia, depression, anxiety, cardiac arrhythmia, hypertension, certain types of cancer, diabetes, infertility, sexual dysfunction and other undesirable conditions.
摘要翻译: 用于调节T型钙离子通道并可适应高通量筛选形式的化合物的基于荧光的测定。 T型通道的调制器可用于纠正功能异常。 这些异常与癫痫,疼痛,精神分裂症,抑郁,焦虑,心律失常,高血压,某些类型的癌症,糖尿病,不孕症,性功能障碍和其他不良状况有关。
-
-
-
-
-
-
-
-
-